Actively Recruiting

Age: 18Years +
All Genders
NCT07336225

CMR-Based Prognostic Study in Patients With Cardiac Implantable Electronic Devices

Led by Chinese Academy of Medical Sciences, Fuwai Hospital · Updated on 2026-01-27

1500

Participants Needed

1

Research Sites

1617 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cardiac implantable electronic devices (CIEDs) are widely used to treat patients with heart failure, malignant arrhythmias, and other conditions. However, accurately identifying suitable candidates for CIED implantation remains a clinical challenge. Cardiovascular magnetic resonance imaging (CMR) provides a comprehensive assessment of cardiac structure, function, and tissue characteristics, facilitating evaluation of the myocardial substrate for arrhythmias. This study aims to evaluate the prognostic value of multiparametric CMR-derived imaging markers in CIED patients through preoperative CMR examinations. Imaging parameters of interest include structural-functional indices, myocardial strain, late gadolinium enhancement, entropy, and T1 and T2 mapping. Long-term clinical outcomes will be obtained from existing medical records and follow-up. The primary endpoint is sudden cardiac death (SCD) or SCD-equivalent events, defined as SCD, resuscitated cardiac arrest, sustained ventricular tachycardia or ventricular fibrillation, or appropriate ICD therapy. Secondary endpoints include all-cause mortality or heart failure rehospitalization. This study aims to elucidate the role of CMR in assessing CIED treatment indications and long-term risk stratification, thereby helping to optimize CIED implantation decisions.

CONDITIONS

Official Title

CMR-Based Prognostic Study in Patients With Cardiac Implantable Electronic Devices

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (≥18 years old)
  • Patients with guideline-based reasons for cardiac implantable electronic device therapy, including pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy
  • Patients who had cardiovascular magnetic resonance imaging as part of routine clinical evaluation before CIED implantation or consideration
Not Eligible

You will not qualify if you...

  • Patients under 18 years old
  • Patients with non-diagnostic or poor-quality CMR images preventing reliable analysis
  • Patients with incomplete key clinical data or missing follow-up for primary outcome
  • Patients with prior heart transplantation or ventricular assist device implantation before CMR
  • Patients with congenital heart disease requiring surgical correction

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing, China

Actively Recruiting

Loading map...

Research Team

X

Xinqiao Lian

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here